FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

DHS says ICE agents rammed by vehicles amid Minneapolis enforcement surge: ‘Aggressively assaulted’

Ilhan Omar vows ‘not to give ICE a single cent’ in heated congressional funding fight

ALERT: Dem Rep Publicly Supports Assault on Christian Worship Service by Leftist Agitators

One Incredibly Simple Map Explains Why Greenland Is 100 Percent Vital to US Security

Tariffs, Greenland, and a ‘nasty’ binder clip: Five takeaways from Trump’s marathon first-anniversary press briefing

California GOP asks Supreme Court to block House map ahead of midterm elections

Gavin Newsom Freaks Out After Arriving at Davos and Hearing What World Leaders Are Saying About Trump

Trump says ‘you’ll see’ when asked how far he’ll go on Greenland takeover

Minnesota Gov Walz invites Trump to visit state to ‘see our values in action’ after ICE feud

Manhunt Underway After Judge and Wife Are Shot Through Their Front Door

Illegal immigrant accused in DUI crash that killed college soccer player, girlfriend: report

Minnesota police chiefs allege some ICE agents racially profiled US citizens, including off-duty officers

Supreme Court keeps nation waiting on Trump tariff decision, releases 3 lower-profile opinions

Lawmaker says Trump could keep housing-cost pledge by backing Democratic bill in rare call for common ground

To Combat ICE, Reckless Dem. Rep. Spreads Plan That Will Destroy 911 System, Cut Off Citizens from Police, Fire, Medical Help

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”